富力(02777.HK)止跌曾反彈14% 獲主要股東提供80億元資金支持
富力地產(02777.HK)獲兩執董兼主要股東提供80億元資金支持,該股扭五連跌,今早由至少逾八年低位曾反彈14%高見4.9元,現報4.68元,反彈9%,成交809萬股。
富力昨天收市後公布,將獲公司執董兼大股東李思廉及張力提供約80億元支持,預計未來一至兩個月內完成,公司預期今天(21日)將收到約24億元。集團表示,於主要股東提供財務支持後及按現有可供使用現金,除非出現不可預見情況,即使沒有計及任何進一步外部融資或由公司非持續性業務如資產出售帶來之現金流,公司預期將有足夠資金應付短期內到期債務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.